


Yposkesi’s clinical batches of the G1XCGD lentiviral vector used in rare immune system disease study

Cynbiose receives €1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases

Nuvisan Pharma Services acquires Inamed GmbH

PDC*line Pharma raises €20 million in Series B financing round

Advanced BioDesign joins ENHPATHY corsortium to increase its knowledge in genetic alterations in hematologic cancers

Biotech start-up Seekyo raises €800k with leverage from French Tech Seed Fund

Yposkesi sélectionné pour la Grande Exposition du Fabriqué en France à l’Elysée les 18 et 19 janvier 2020

Urania Therapeutics benefits from €1.7M Deeptech financing from Bpifrance
